Navigation Links
Insmed Incorporated Provides Regulatory Update on ARIKACE® in Non-Tuberculous Mycobacteria Indication
Date:10/14/2011

MONMOUTH JUNCTION, N.J., Oct. 14, 2011 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the Company has been notified by the U.S. Food and Drug Administration (FDA) that it is continuing the clinical hold previously placed on Insmed's phase 3 clinical trial for ARIKACE® (liposomal amikacin for inhalation) in patients with non-tuberculous mycobacterial (NTM) lung disease.  

As announced on August 1, 2011, the clinical holds placed on ARIKACE in NTM and Cystic Fibrosis (CF) patients with Pseudomonas lung infections were based on an initial review by FDA of the interim results of a long-term rat inhalation carcinogenicity study reported to the Agency by Insmed with ARIKACE.  At that time, FDA requested additional information on ARIKACE and data from the rat study.  Insmed submitted its complete response to this request before the end of August.  

Insmed has been informed by FDA that, based on its review of the information provided to date, including the rat inhalation carcinogenicity study results, the Agency has insufficient information to assess the risks of ARIKACE in NTM patients in the planned phase 3 clinical trial.  FDA is requiring that Insmed conduct a phase 2 clinical trial in adult NTM patients intended to provide proof-of-concept efficacy and safety data for ARIKACE in NTM before the Company can proceed with a phase 3 clinical trial.  In addition, Insmed will also need to further revise the assessment of the rat carcinogenicity study findings in the investigator brochure.

"Now that we have responses from FDA with respect to both clinical holds, we are seeking further input from the Agency in order to gain a better understanding of their requests regarding CF and NTM," said Timothy Whitten, President and CEO of Insmed.  "Once we have received clarifications from FDA on their requests, and have sufficient opportunity to evaluate poten
'/>"/>

SOURCE Insmed Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Insmed Incorporated Provides Regulatory Update
2. Insmed to Present at Sixth Annual JMP Securities Healthcare Conference
3. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011
4. Insmeds ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections
5. Insmed Announces First Quarter 2011 Financial Results
6. Insmed to Host 2011 First Quarter Earnings Conference Call
7. Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication
8. One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective
9. Insmed Shareholders Approve Conversion of Series B Conditional Convertible Preferred Stock and Reverse Stock Split
10. Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call
11. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Calif. , June 30, 2015 Velos, ... specialty medicine, continues to grow and add customers who ... 40% of the 62 CTSAs awarded by the National ... research information management. This is among the largest such ... "Our presence in the CTSA community keeps growing as ...
(Date:6/30/2015)... Millar, Inc. , a leader in catheter-based and wireless ... Craig Thummel , President/CEO and member of the ... the Company. The Company also announced its leadership succession ... Management team as his successors. The Board of Directors ... Sales and Marketing, as President, and also a member ...
(Date:6/30/2015)... 2015 Olympus, a global technology leader ... and surgical procedures, among other core businesses, announced ... equipment at no additional charge. Olympus is the ... of guarantee. The service became available to customers ... year. Olympus, Full Service Agreement ...
Breaking Medicine Technology:Velos continues adding CTSA customers - 40% now use Velos products 2Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3
(Date:6/30/2015)... ... June 30, 2015 , ... ... As a subcontractor, ESSC ranked as one of their top 20 installing dealers ... last quarter of 2014. Providers are based on timeliness, service, installation, paperwork and ...
(Date:6/30/2015)... , ... June 30, 2015 , ... Ticket Down announces that they have slashed prices ... the legendary Pantages Theatre. For the past 26 years, “The Phantom of the ... 1988, this musical, originally written by Gaston Leroux, and converted into a musical by Andrew ...
(Date:6/30/2015)... ... ... Down is a reliable source for last minute tickets for The Rolling Stones at ... North America in conjunction with their 2015 “Zip Code Tour.” , The Stones have been ... their twenties. Some of the most beloved songs that this iconic group has performed ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... Texas have launched a ‘responsive design’ website to inform potential sinus surgery patients ... them. , The website includes information about a wide variety of ENT issues ...
(Date:6/30/2015)... ... 30, 2015 , ... The Blue Cross and Blue Shield of Minnesota Foundation ... state. The projects improve community health by focusing on the social and economic factors ... renewable for a second year in 2016 based on progress in 2015. , “We ...
Breaking Medicine News(10 mins):Health News:Electronic Security Specialists (E.S.S.C. Inc) Awarded Top Service Provider Award By Monitronics 2Health News:Phantom of the Opera Tickets at The Pantages Theatre in Los Angeles: Ticket Down Has Slashed Prices On All Phantom of the Opera Tickets in LA at The Pantages Theatre 2Health News:The Rolling Stones Tickets in Raleigh at Carter Finley Stadium: Ticket Down Offers Last Minute Tickets for the Rolling Stones and Avett Brothers in Raleigh 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 3Health News:Blue Cross and Blue Shield of Minnesota Foundation Awards $1.5 Million 2
... gift of your time with kids is one option to ... physical development should be important considerations when you,re looking for ... the Sciences in Philadelphia. , "Parents often feel like ... moment," Paula Kramer, chairman and professor of occupational therapy, said ...
... many Australians, from the elderly to the very active, restricting the ... all natural arthritis treatment called Mobicosa to help combat this by ... ... Melbourne, VIC (PRWEB) December 18, 2008 -- Arthritis and stiff ...
... Inc. (Amex: BUF ) today reported that ... US LLC (the "Exchange") stating that a review of ... 2008, indicated the Company was not in compliance with ... Guide"), namely Section 1003(a)(i), with stockholders, equity of less ...
... Visions, Inc., a premier,event production and audio-visual integration ... was acquired by Interactive Holdings, a leading,communication solutions ... Creative Visions is best known for producing world ... Palace of Versailles, Sydney Opera House,Blenheim Palace and ...
... Pa., Dec. 17 Carla Bluhm, a developmental psychologist and ... Clendenin, Allegheny class of 2007, have recently completed a book ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080220/DC14623 ) , ... the Mirror: Identity and the New Science of Face Transplants" ...
... QUEBEC CITY, Dec. 17 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: ... tests and delivering lab services, today reported financial and ... year ended October 31, 2008. The Company announced a ... the fourth quarter ending October 31, 2008, and a ...
Cached Medicine News:Health News:'Hot' Toys May Not Be the Best Present 2Health News:Patients Benefit From Mobicosa, A Unique, Natural Arthritis Treatment Available At Your Chemist Shop 2Health News:MINRAD Receives Notice of Failure to Satisfy a Continued Listing Rule from NYSE Alternext 2Health News:MINRAD Receives Notice of Failure to Satisfy a Continued Listing Rule from NYSE Alternext 3Health News:Creative Visions Acquired by Interactive Holdings 2Health News:Creative Visions Acquired by Interactive Holdings 3Health News:Psychology of Face Transplants is Subject of New Book by Allegheny College Professor 2Health News:DiagnoCure announces fourth quarter 2008 and year-end results 2Health News:DiagnoCure announces fourth quarter 2008 and year-end results 3Health News:DiagnoCure announces fourth quarter 2008 and year-end results 4Health News:DiagnoCure announces fourth quarter 2008 and year-end results 5Health News:DiagnoCure announces fourth quarter 2008 and year-end results 6Health News:DiagnoCure announces fourth quarter 2008 and year-end results 7
Sleeve extends 3mm beyond end, .90mm (20G) probe, 1.4mm (17G) sleeve...
Cannula: .90mm x 28mm (20 G x 1 1/8 in) Handle: 9.3cm (3 5/8 in) long, Flute, .90 x 28mm, vacuum handle [Charles]...
Ideal for short scleral tunnel and trabecular meshwork incisions...
Rounded tip for even incisions reducing post-op astigmatism...
Medicine Products: